|
 |
|
|||||||
|
|||||||||
Copyright © ERS Journals Ltd 1995
Original Articles |
Fibrosing alveolitis in systemic sclerosis: increase in memory T-cells in lung interstitium
Despite the large numbers of T-cells present in the lungs in fibrosing alveolitis, their pathogenetic role is poorly understood. If these cells are involved in pathogenesis, they are more likely to express the CD45RO+ memory phenotype. To test this hypothesis, open lung biopsies from patients with fibrosing alveolitis associated with systemic sclerosis (FASSc) were compared with grossly normal lung taken from the periphery of lobes resected for lung cancer. Biopsies from eight patients with FASSc were compared with tissue from seven cancer controls. Paraffin sections were stained with a polyclonal anti-CD3 antibody for T-lymphocytes, monoclonal anti-CD45 antibody for leucocyte common antigen, and monoclonal anti-CD45RO antibody for primed T-lymphocytes. Staining was assessed quantitatively by computerized image analysis: in each case, the number of immunopositive cells was related to alveolar wall area and alveolar wall length. Mean alveolar wall thickness was increased in patients with FASSc (60.7 +/- 24.0 microns) compared with cancer controls (15.7 +/- 5.3 microns). Patients with FASSc had greater numbers of CD45+, CD3+ and CD45RO+ cells.mm-1 alveolar wall length compared with the controls. CD45RO+ cells made up 77% (median) of the CD3+ cells in FASSc, and their numbers per unit alveolar wall length were positively associated with alveolar wall thickness (r = 0.61). In conclusion, in fibrosing alveolitis of systemic sclerosis, most interstitial T-lymphocytes express the phenotype of memory cells; these cells are likely to be involved in the persistent inflammatory process.
This article has been cited by other articles:
|
|
 |
|
  H. Yasuoka, Y. Yamaguchi, and C. A. Feghali-Bostwick The Pro-Fibrotic Factor IGFBP-5 Induces Lung Fibroblast and Mononuclear Cell Migration Am. J. Respir. Cell Mol. Biol., August 1, 2009; 41(2): 179 - 188. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. G. Luzina, N. W. Todd, A. T. Iacono, and S. P. Atamas Roles of T lymphocytes in pulmonary fibrosis J. Leukoc. Biol., February 1, 2008; 83(2): 237 - 244. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Hayakawa, M. Hasegawa, T. Matsushita, K. Yanaba, M. Kodera, K. Komura, K. Takehara, and S. Sato Increased cutaneous T-cell-attracting chemokine levels in sera from patients with systemic sclerosis Rheumatology, July 1, 2005; 44(7): 873 - 878. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M R Hussein, H I Hassan, E R M Hofny, M Elkholy, N A Fatehy, A E A Abd Elmoniem, A M Ezz El-Din, O A Afifi, and H G Rashed Alterations of mononuclear inflammatory cells, CD4/CD8+ T cells, interleukin 1{beta}, and tumour necrosis factor {alpha} in the bronchoalveolar lavage fluid, peripheral blood, and skin of patients with systemic sclerosis J. Clin. Pathol., February 1, 2005; 58(2): 178 - 184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D Farge, J Passweg, J M van Laar, Z Marjanovic, C Besenthal, J Finke, H H Peter, F C Breedveld, W E Fibbe, C Black, et al. Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry Ann Rheum Dis, August 1, 2004; 63(8): 974 - 981. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G H Stummvoll, M Aringer, J Grisar, C W Steiner, J S Smolen, R Knobler, and W B Graninger Increased transendothelial migration of scleroderma lymphocytes Ann Rheum Dis, May 1, 2004; 63(5): 569 - 574. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. I. Sakkas, B. Xu, C. M. Artlett, S. Lu, S. A. Jimenez, and C. D. Platsoucas Oligoclonal T Cell Expansion in the Skin of Patients with Systemic Sclerosis J. Immunol., April 1, 2002; 168(7): 3649 - 3659. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.M. du Bois and A.U. Wells Cryptogenic fibrosing alveolitis/idiopathic pulmonary fibrosis Eur. Respir. J., July 1, 2001; 18(32_suppl): 43S - 55s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Binks, J R Passweg, D Furst, P McSweeney, K Sullivan, C Besenthal, J Finke, H H Peter, J van Laar, F C Breedveld, et al. Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease Ann Rheum Dis, June 1, 2001; 60(6): 577 - 584. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. H. Stummvoll, M. Aringer, J. S. Smolen, M. Koller, H. P. Kiener, C. W. Steiner, B. Bohle, R. Knobler, and W. B. Graninger Derangement of apoptosis-related lymphocyte homeostasis in systemic sclerosis Rheumatology, December 1, 2000; 39(12): 1341 - 1350. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. I. Sakkas, C. Tourtellotte, S. Berney, A. R. Myers, and C. D. Platsoucas Increased Levels of Alternatively Spliced Interleukin 4 (IL-4delta 2) Transcripts in Peripheral Blood Mononuclear Cells from Patients with Systemic Sclerosis Clin. Vaccine Immunol., September 1, 1999; 6(5): 660 - 664. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |